InMed Pharmaceuticals Inc (INM)
4.53
+0.03
(+0.67%)
USD |
NASDAQ |
Nov 26, 16:00
4.55
+0.02
(+0.44%)
After-Hours: 06:39
InMed Pharmaceuticals Revenue (Quarterly): 1.265M for Sept. 30, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 1.265M |
| June 30, 2024 | 1.283M |
| March 31, 2024 | 1.173M |
| December 31, 2023 | 1.240M |
| September 30, 2023 | 0.9019M |
| June 30, 2023 | 2.311M |
| March 31, 2023 | 1.034M |
| December 31, 2022 | 0.4698M |
| September 30, 2022 | 0.3208M |
| June 30, 2022 | 0.5148M |
| March 31, 2022 | 0.3096M |
| December 31, 2021 | 0.2651M |
| September 30, 2021 | |
| June 30, 2021 | |
| March 31, 2021 | |
| December 31, 2020 | |
| September 30, 2020 | |
| June 30, 2020 | |
| March 31, 2020 | |
| December 31, 2019 | |
| September 30, 2019 | |
| June 30, 2019 | |
| March 31, 2019 | |
| December 31, 2018 | |
| September 30, 2018 |
| Date | Value |
|---|---|
| June 30, 2018 | |
| March 31, 2018 | |
| December 31, 2017 | |
| September 30, 2017 | |
| June 30, 2017 | |
| March 31, 2017 | |
| December 31, 2016 | |
| September 30, 2016 | |
| June 30, 2016 | |
| March 31, 2016 | |
| December 31, 2015 | |
| September 30, 2015 | |
| June 30, 2015 | |
| March 31, 2015 | |
| December 31, 2014 | |
| September 30, 2014 | |
| June 30, 2014 | |
| March 31, 2014 | |
| December 31, 2013 | |
| September 30, 2013 | |
| June 30, 2013 | |
| March 31, 2013 | |
| December 31, 2012 | |
| September 30, 2012 | |
| June 30, 2012 |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
0.2651M
Minimum
Dec 2021
2.311M
Maximum
Jun 2023
0.9239M
Average
0.9679M
Median
Revenue (Quarterly) Benchmarks
| Rimrock Gold Corp | -- |
| CeCors Inc | -- |
| Venus Concept Inc | 15.01M |
| Atlas Global Brands Inc | 6.315M |
| Aurinia Pharmaceuticals Inc | 67.77M |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -1.678M |
| Total Expenses (Quarterly) | 3.019M |
| EPS Diluted (Quarterly) | -54.20 |
| Enterprise Value | -2.33M |
| Gross Profit Margin (Quarterly) | 39.02% |
| Profit Margin (Quarterly) | -132.7% |
| Earnings Yield | -1.44K% |
| Normalized Earnings Yield | -1457.58 |